Telisotuzumab vedotin with erlotinib in the treatment of non-small cell lung cancer: a well MET combination?

ABSTRACT:

SUBMITTER: Kujtan L 

PROVIDER: S-EPMC10483073 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature